Xuechu Zhen[Author] - Search Results

Year	Number of Results
2002	2
2003	2
2004	1
2005	2
2006	2
2007	9
2008	11
2009	7
2010	8
2011	6
2012	7
2013	12
2014	19
2015	16
2016	13
2017	10
2018	7
2019	4
2020	11
2021	6
2022	8
2023	6
2024	3

1

Early glycolytic reprogramming controls microglial inflammatory activation.

Cheng J, Zhang R, Xu Z, Ke Y, Sun R, Yang H, Zhang X, Zhen X, Zheng LT. Cheng J, et al. Among authors: zhen x. J Neuroinflammation. 2021 Jun 9;18(1):129. doi: 10.1186/s12974-021-02187-y. J Neuroinflammation. 2021. PMID: 34107997 Free PMC article.

2

Sigma-1 receptor-regulated efferocytosis by infiltrating circulating macrophages/microglial cells protects against neuronal impairments and promotes functional recovery in cerebral ischemic stroke.

Zhang G, Li Q, Tao W, Qin P, Chen J, Yang H, Chen J, Liu H, Dai Q, Zhen X. Zhang G, et al. Among authors: zhen x. Theranostics. 2023 Jan 1;13(2):543-559. doi: 10.7150/thno.77088. eCollection 2023. Theranostics. 2023. PMID: 36632219 Free PMC article.

3

Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases.

Jia J, Cheng J, Wang C, Zhen X. Jia J, et al. Among authors: zhen x. Front Cell Neurosci. 2018 Sep 20;12:314. doi: 10.3389/fncel.2018.00314. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30294261 Free PMC article. Review.

4

Targeted to neuronal organelles for CNS drug development.

Ying Z, Ye N, Ma Q, Chen F, Li N, Zhen X. Ying Z, et al. Among authors: zhen x. Adv Drug Deliv Rev. 2023 Sep;200:115025. doi: 10.1016/j.addr.2023.115025. Epub 2023 Jul 28. Adv Drug Deliv Rev. 2023. PMID: 37516410 Review.

5

Sigma-2 receptor ligands: neurobiological effects.

Guo L, Zhen X. Guo L, et al. Among authors: zhen x. Curr Med Chem. 2015;22(8):989-1003. doi: 10.2174/0929867322666150114163607. Curr Med Chem. 2015. PMID: 25620095 Review.

6

Emerging novel approaches to drug research and diagnosis of Parkinson's disease.

Zhen XC, Chu HY. Zhen XC, et al. Acta Pharmacol Sin. 2020 Apr;41(4):439-441. doi: 10.1038/s41401-020-0369-7. Epub 2020 Mar 13. Acta Pharmacol Sin. 2020. PMID: 32203079 Free PMC article. No abstract available.

7

A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II.

Liu Y, Iqbal A, Li W, Ni Z, Wang Y, Ramprasad J, Abraham KJ, Zhang M, Zhao DY, Qin S, Loppnau P, Jiang H, Guo X, Brown PJ, Zhen X, Xu G, Mekhail K, Ji X, Bedford MT, Greenblatt JF, Min J. Liu Y, et al. Among authors: zhen x. Nat Commun. 2022 Sep 16;13(1):5453. doi: 10.1038/s41467-022-33229-5. Nat Commun. 2022. PMID: 36114190 Free PMC article.

8

Neuropharmacological Actions of Metformin in Stroke.

Jia J, Cheng J, Ni J, Zhen X. Jia J, et al. Among authors: zhen x. Curr Neuropharmacol. 2015;13(3):389-94. doi: 10.2174/1570159x13666150205143555. Curr Neuropharmacol. 2015. PMID: 26411966 Free PMC article. Review.

9

Dysregulation of miRNA and its potential therapeutic application in schizophrenia.

Cao T, Zhen XC. Cao T, et al. CNS Neurosci Ther. 2018 Jul;24(7):586-597. doi: 10.1111/cns.12840. Epub 2018 Mar 12. CNS Neurosci Ther. 2018. PMID: 29529357 Free PMC article. Review.

10

Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis.

Yan P, Li N, Ma M, Liu Z, Yang H, Li J, Wan C, Gao S, Li S, Zheng L, Waddington JL, Xu L, Zhen X. Yan P, et al. Among authors: zhen x. Signal Transduct Target Ther. 2023 Sep 18;8(1):355. doi: 10.1038/s41392-023-01578-2. Signal Transduct Target Ther. 2023. PMID: 37718358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

150 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year